These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2283265)

  • 1. Magnetic resonance contrast media for myocardial imaging.
    Higgins CB; Saeed M; Wendland MF
    Invest Radiol; 1990 Sep; 25 Suppl 1():S74. PubMed ID: 2283265
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast enhancement for the myocardium.
    Higgins CB; Saeed M; Wendland M
    Magn Reson Med; 1991 Dec; 22(2):347-53; discussion 364-5. PubMed ID: 1812369
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for differential enhancement of myocardial ischemia using echoplanar imaging.
    Wendland MF; Saeed M; Higgins CB
    Invest Radiol; 1991 Nov; 26 Suppl 1():S236-8; discussion S245-7. PubMed ID: 1808137
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of reperfused myocardial infarctions with T1-enhancing and magnetic susceptibility-enhancing contrast media.
    Saeed M; Wendland MF; Higgins CB
    Invest Radiol; 1991 Nov; 26 Suppl 1():S239-41; discussion S245-7. PubMed ID: 1808138
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA.
    Kucharczyk J; Asgari H; Mintorovitch J; Vexler Z; Moseley M; Watson A; Rocklage S
    Invest Radiol; 1991 Nov; 26 Suppl 1():S250-2; discussion S253-4. PubMed ID: 1808141
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Gd- and Dy-chelates for T2 contrast-enhanced imaging.
    Moseley ME; Vexler Z; Asgari HS; Mintorovitch J; Derugin N; Rocklage S; Kucharczyk J
    Magn Reson Med; 1991 Dec; 22(2):259-64; discussion 265-7. PubMed ID: 1812356
    [No Abstract]   [Full Text] [Related]  

  • 7. Contrast-enhanced MRI for quantification of myocardial viability.
    Wendland MF; Saeed M; Lund G; Higgins CB
    J Magn Reson Imaging; 1999 Nov; 10(5):694-702. PubMed ID: 10548777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular magnetic resonance imaging: evaluation of myocardial perfusion.
    Anderson CM; Brown JJ
    Coron Artery Dis; 1993 Apr; 4(4):354-60. PubMed ID: 8261208
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of myocardial ischemia and infarction by contrast enhanced magnetic resonance imaging.
    Wolfe CL
    Cardiol Clin; 1989 Aug; 7(3):685-96. PubMed ID: 2670233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of regional myocardial ischemia using contrast-enhanced dynamic magnetic resonance imaging in an experimental canine model of hemodynamically significant coronary arterial stenosis.
    Higgins CB; Saeed M; Wendland M; Sakuma H; Szolar D; Geschwind JF
    Acad Radiol; 1996 Aug; 3 Suppl 2():S392-4. PubMed ID: 8796611
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging.
    Johnston DL; Liu P; Lauffer RB; Newell JB; Wedeen VJ; Rosen BR; Brady TJ; Okada RD
    J Nucl Med; 1987 May; 28(5):871-7. PubMed ID: 3572546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentration.
    Wang SC; White DL; Pope JM; Brasch RC
    Invest Radiol; 1990 Sep; 25 Suppl 1():S44-5. PubMed ID: 2283253
    [No Abstract]   [Full Text] [Related]  

  • 13. Contrast agents in acute myocardial infarction.
    Hemmingsson A; Bjerner T; Ericsson A; Johansson L; Ahlström H
    MAGMA; 2001 May; 12(2-3):96-8. PubMed ID: 11390263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-DTPA-enhanced magnetic resonance imaging of the isolated rat heart after ischemia and reperfusion.
    de Roos A; Mohanlal RW; van Vaals JJ; Bergman AH; Doornbos J; Matheijssen NA; van der Wall EE; van der Laarse A
    Invest Radiol; 1991 Dec; 26(12):1060-4. PubMed ID: 1765438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease.
    Manning WJ; Atkinson DJ; Grossman W; Paulin S; Edelman RR
    J Am Coll Cardiol; 1991 Oct; 18(4):959-65. PubMed ID: 1894870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical hepatic imaging with paramagnetic positive enhancers.
    Bernardino ME
    Magn Reson Med; 1991 Dec; 22(2):334-8; discussion 343-6. PubMed ID: 1812367
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in macrocyclic gadolinium complexes as magnetic resonance imaging contrast agents.
    Meyer D; Schaefer M; Doucet D
    Invest Radiol; 1990 Sep; 25 Suppl 1():S53-5. PubMed ID: 2132570
    [No Abstract]   [Full Text] [Related]  

  • 18. MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
    Leander P; Golman K; Klaveness J; Holtz E; Olsson M; Leunbach I
    Invest Radiol; 1990 Oct; 25(10):1130-4. PubMed ID: 2127772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitated magnetic resonance imaging diagnosis of pulmonary disease using a macromolecular blood-pool contrast agent, polylysine-(Gd-DTPA)40.
    Brasch RC; Berthezene Y; Vexler VS; Moseley M; Clément O; Muehler A; Price D; Jerome H
    Invest Radiol; 1991 Nov; 26 Suppl 1():S42-5; discussion S60-4. PubMed ID: 1808147
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-contrast MR imaging of reperfused porcine myocardial infarction. An experimental study using Gd-DTAA and Dy-DTPA-BMA.
    Nilsson S; Wikström G; Ericsson A; Wikström M; Oksendal A; Waldenström A; Hemmingsson A
    Acta Radiol; 1996 Jan; 37(1):27-35. PubMed ID: 8611319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.